PFIZER 446 (Renese-R polythiazide 2 mg / reserpine 0.25 mg)
Generic Name: polythiazide/reserpine
Pill imprint PFIZER 446 has been identified as Renese-R polythiazide 2 mg / reserpine 0.25 mg.
Renese-R is used in the treatment of high blood pressure and belongs to the drug class antiadrenergic agents (peripheral) with thiazides. Risk cannot be ruled out during pregnancy. Renese-R polythiazide 2 mg / reserpine 0.25 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- PFIZER 446
- polythiazide 2 mg / reserpine 0.25 mg
- Prescription only
- Drug Class:
- Antiadrenergic agents (peripheral) with thiazides
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Pfizer, Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- FD&C Blue No. 1
dibasic calcium phosphate
sodium lauryl sulfate
Note: Inactive ingredients may vary.
More about Renese-R (polythiazide / reserpine)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Interactions
- Support Group
- 0 Reviews – Add your own review/rating
- Drug class: antiadrenergic agents (peripheral) with thiazides
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.